Bullish Article Clashes with Cautious DeepValue Report on Pagaya's AI Credit Model

What happened

A Seeking Alpha article published on April 15, 2026, argues that Pagaya is mispriced as a traditional lender and offers 62% upside to $21.40, citing its AI-driven platform and oversubscribed ABS issuances. However, the DeepValue master report, based on recent SEC filings, maintains a WAIT rating due to negative capital markets execution fees and rising credit reserves that threaten profitability. The report highlights Pagaya's sensitivity to ABS pricing, with management quantifying that a 100 basis point discount could reduce upfront fees by $10 million, undermining revenue growth. Key risks include concentrated funding sources and a 5% risk-retention requirement, which could exacerbate capital strain during market stress. Thus, while the article is optimistic, the underlying data suggests investors should await clearer signs of economic improvement before acting.

Implication

The divergence between bullish external analysis and cautious internal data underscores significant uncertainty around Pagaya's ability to convert volume growth into durable profits, given recent negative execution fees and credit reserve builds. DeepValue's WAIT recommendation is justified by these documented financial pressures, which the Seeking Alpha article overlooks, emphasizing the need for critical scrutiny of promotional claims. Upcoming ABS transactions and filings will be pivotal in validating whether Pagaya can achieve profitable unit economics, as the stock's downside risk includes a bear case of $7 if funding costs worsen or credit deteriorates. Without evidence of improved execution fees or stable reserves, investors risk capital losses in a scenario where spread pressure persists, outweighing near-term upside potential. Therefore, adopting a wait-and-see approach allows for better risk management, positioning only if positive indicators emerge in the next 3-6 months.

Thesis delta

The Seeking Alpha article does not materially shift the DeepValue investment thesis, as it lacks new data to counter the reported negative execution fees and credit reserve builds from recent SEC filings. DeepValue's thesis remains unchanged, emphasizing that Pagaya's near-term upside depends on observable proof of positive unit economics, not just ABS access, and the WAIT rating is still appropriate until such evidence surfaces.